Actavis CEO: Teva-Mylan Deal Overlap 'Value Destroying'

Brent Saunders, chief executive officer of Actavis Plc, talks about the company's acquisition of Allergan Inc., the decision to raise Actavis's full-year forecast and Teva Pharmaceutical Industries Ltd.'s bid for Mylan NV. Saunders speaks with Pimm Fox and Olivia Sterns on Bloomberg Television's "Bloomberg Markets." (Source: Bloomberg)

Full Show: Best of Bloomberg Technology (08/18)
03:54 - The best interviews and technology news highlights from the week are brought together in "Best of Bloomberg Technology," a weekly long-form program hosted by Bloomberg Technology's Emily Chang. (Source: Bloomberg)
  • Full Show: Bloomberg Real Yield (08/18)
  • Foot Locker Shares Plummet as 2Q Results Disappoint
  • UBS: U.S. Economic Outlook 'Not Particularly Remarkable'